The good news is that once you have done it a few times, it is very easy to do from that point forward
CJC-1295 Clinical Evidence The Foundation for GH Amplification In two randomised, placebo-controlled, double-blind clinical trials in healthy subjects aged 2161 years, subcutaneous administration of CJC-1295 produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean plasma IGF-1 concentrations of 1.5 to 3-fold for 911 days
A white patch is not a personality test
Clinical Assessment management Consider including in your assessments a recommendation to - - check B12 levels prior to the next injection, or every 3 months, to clarify status
Monitoring Requirements Post-initiation monitoring under Endocrine Society guidance includes testosterone level checks at three to six months, hematocrit monitoring (withholding therapy if hematocrit exceeds 54%), and PSA surveillance at 3 and 12 months